Reach Us +44-1764910199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

CBN: The cancer fighting Cannabinoid

4th Edition of World Congress on Cancer Research, Survivorship and Management Conference
October 08-09, 2018 Moscow, Russia

Mike Robinson

American Academy of Cannabinoid Medicine, USA

Keynote: Arch Cancer Res

DOI: 10.21767/2254-6081-C3-010

Abstract

CBN, cannabinol, is a mildly psychoactive cannabinoid found within the cannabis plant. We examine the very complex mechanisms that give allowance for this cannabinoids entrance into the cell membrane and its effect on cannabinoid receptors and the inhibition of the enzyme adenylate cyclase that is responsible for phosphate production. Prior study bears weight accordingly; we examine this phosphate as a potent energy source, the enzymes responsible for cell replication cycle and inhibition thereof. Moreover, how IL-2, (Interleukin-2), a type of cytokine signaling molecule in the immune system stops being produced when immune T cells are exposed to cannabinoids. How IL-2 stimulates the cell cycle via promotion of the c-Fos protein and is responsible for modulation of the immune response. This is shown by Faubert and Kaminski, that administration of CBN can slow cell replication and endure cell death (apoptosis).

Biography

Mike Robinson is Director of Communications, American Academy of Cannabinoid Medicine, Cannabinoid Medicine Research Analyst. Few out of the world of medicinal cannabis have heard his inside story, a multiple cancer survivor who used cannabis oils extensively as well for severe epilepsy, chronic Lyme disease, PTSD, and in management. Over the last 5 years he has shared his journey and analytics on cannabinoid medicine research globally while assisting patients and clinicians during his own journey. An extensive background includes being an effective leader of a large cannabis compassion program providing to the disadvantages that treated countless medicinal cannabis consumers with various alternative protocol treatments. He is a published Journalist, Research Analyst, and former Chartered Accountant in State Lobbyist 1997, pro bono non-attorney representative for children with disabilities nationwide for over 2 decades, a member of the Board of Directors for Big Brothers and Sisters, the founder of multiple non-profits that advocate/advocated for the rights of disabled children.

E-mail: [email protected]

Flyer image

Abstracted/Indexed in

  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs